Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 USD | -2.68% | -12.23% | +189.17% |
04-18 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
03-06 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |